Antibacterial Agents TRIZ Cases

Modifying phenicol structures overcomes florfenicol resistance, restoring efficacy against Mannheimia haemolytica and Pasteurella multocida.

Merging pharmacophores into single molecules reduces treatment duration while maintaining effectiveness against resistant strains.

Formula I compounds inhibit neutral endopeptidase to block atrial natriuretic peptide degradation, extending therapeutic duration for cardiovascular treatment.

Fusion polypeptides combine endolysins with antimicrobial peptides to overcome outer membrane shielding in Salmonella strains.

Adherent filters replace cationic detergent treatment to eliminate polysaccharide loss while maintaining high purity levels.

Insertion device electronics assembly generates light internally within opaque media, enabling volumetric photoactivated drug activation.

Propylene glycol replaces toxic Tween-80 in a solvent mixture, enabling safe administration of N,N'-diaminodiphenyl sulfone for rapid absorption.

A self-immolative linker stabilizes antibody-drug conjugates in circulation through enzymatic triggering.

Modified GBS capsular saccharides conjugated to carrier proteins induce robust immune responses against variable strains.

Fusion protein links target antigens to bifidobacterial membrane proteins for surface display.

Heating amorphous drug to 30-100°C yields stable Form III, preventing recrystallization and improving oral bioavailability.

Synthesizing a hybrid polycyclic structure overcomes microbial resistance while maintaining high yield for pharmaceutical use.

A 15-valent pneumococcal conjugate vaccine combines distinct polysaccharide-protein components to induce robust antibody responses across multiple serotypes.

Recombinant CD6 ectodomain aggregates Gram-positive and Gram-negative bacteria, reducing pro-inflammatory cytokine levels in septic shock.

Metalloenzyme inhibitor compounds utilize specific metal-binding groups to achieve targeted inhibition while minimizing off-target effects on related enzymes.

Peptide coatings prevent biofilm formation on medical devices, avoiding antibiotic resistance and cytotoxicity.

A diagnostic method uses endotoxin tolerance gene signatures to detect sepsis and predict severe outcomes.

A reversible staining method using Fab fragments enables precise target cell isolation without permanent surface labeling.

Novel thiophene derivatives act as selective S1P1 receptor agonists to modulate lymphocyte distribution.

Isolated heat-stable compounds from Faecalibacterium prausnitzii suppress E. coli virulence without triggering antibiotic resistance.

Circular permutation generates new termini on protein ligands, enabling fusion polypeptides that modulate receptor signaling pathways.

Substituted urea depsipeptides activate bacterial ClpP protease to degrade proteins, eliminating drug-resistant strains and biofilm-associated persister cells.

Suboptimal calcium flux agonists synergize with TLR ligands to amplify immune signaling, reducing cytotoxicity while accelerating wound healing.

Novel 3-phenylpropionic acid derivatives directly activate haem-free soluble guanylate cyclase to stimulate catalytic activity.

A thermo-responsive hydrogel transitions viscosity upon skin contact to sustain bacterial antifungal secretion.

Vacuum mixing sporoderm-broken ganoderma lucidum spores with calcium hydrogen phosphate creates a stable toothpaste composition.

Bdellovibrio bacteriovorus eliminates gram-negative pathogens while preserving beneficial flora, resolving antibiotic resistance and microbiome disruption.

High-aspect-ratio microstructures generate nanoconduits in the stratum corneum to enable transdermal delivery of active substances.

Resazurin reduces bacterial burden in Neisseria and Francisella infections without nephrotoxicity.

A segmented adhesive polymer matrix isolates conductive zones to eliminate parasitic leakage and improve transdermal drug delivery.

Dialysis reduces steroidal detergent concentration below critical micelle levels to enable simultaneous protein folding and lipid bilayer formation.

Isolated anti-microbial adhesion inhibitory fraction A6 blocks pathogen attachment to host cells.

A portable peristaltic vacuum pump applies subatmospheric pressure to a wound dressing for fluid removal.

Characterizing the native VLPT protein enables precise epitope mapping for targeted vaccine design.

A quinolone compound featuring a tri-substituted 3-aminopyrrolidinyl group at position 7 delivers broad-spectrum antibacterial activity against resistant strains.

An incubation with inosine, adenine, pyruvate, and phosphates reverses storage lesions to restore oxygen delivery capacity.

Small molecule heterocyclic compound regulates muscle cell and adipocyte differentiation to treat diabetes, obesity, and dyslipidemia with reduced side effects.

Bacteriophage compositions target pathogenic E. coli strains to eliminate uterine infections, reducing antibiotic resistance and economic losses.

A combination adjuvant formulation merges host defense peptides, polyanionic polymers, and immunostimulatory sequences to stimulate robust immune responses.

Segmenting PSMA inhibitors with cytotoxic drugs targets prostate cancer cells while reducing systemic toxicity.

Novel 2-aminothiophene derivatives target Mycobacterium tuberculosis with potent bactericidal activity.

Isolated pore-forming toxins NetF and NetG establish specific immunoprophylaxis against Clostridium perfringens enteric diseases.

Formula I compounds amplify tulathromycin activity at low doses to overcome microbial resistance mechanisms.

Actinia equina extract coating inhibits biofilm formation on medical devices, eliminating antibiotic resistance risks while maintaining tissue safety.